JP2021535935A5 - - Google Patents

Info

Publication number
JP2021535935A5
JP2021535935A5 JP2021547984A JP2021547984A JP2021535935A5 JP 2021535935 A5 JP2021535935 A5 JP 2021535935A5 JP 2021547984 A JP2021547984 A JP 2021547984A JP 2021547984 A JP2021547984 A JP 2021547984A JP 2021535935 A5 JP2021535935 A5 JP 2021535935A5
Authority
JP
Japan
Prior art keywords
maltodextrin
pluronic
cmc
nanoemulsion
trehalose
Prior art date
Application number
JP2021547984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535935A (ja
JPWO2020035850A5 (https=
Filing date
Publication date
Priority claimed from IL261132A external-priority patent/IL261132A/en
Application filed filed Critical
Publication of JP2021535935A publication Critical patent/JP2021535935A/ja
Publication of JP2021535935A5 publication Critical patent/JP2021535935A5/ja
Publication of JPWO2020035850A5 publication Critical patent/JPWO2020035850A5/ja
Pending legal-status Critical Current

Links

JP2021547984A 2018-08-13 2019-03-11 ナノ乳化による製剤化カンナビス油粉末、その製造方法、及びその使用 Pending JP2021535935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL261132 2018-08-13
IL261132A IL261132A (en) 2018-08-13 2018-08-13 Formulated cannabis oil powder by nanoemulsifycation, methods of producing and uses thereof
PCT/IL2019/050268 WO2020035850A1 (en) 2018-08-13 2019-03-11 Formulated cannabis oil powder by nanoemulsifycation, methods of producing and uses thereof

Publications (3)

Publication Number Publication Date
JP2021535935A JP2021535935A (ja) 2021-12-23
JP2021535935A5 true JP2021535935A5 (https=) 2022-01-25
JPWO2020035850A5 JPWO2020035850A5 (https=) 2022-01-25

Family

ID=63998426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021547984A Pending JP2021535935A (ja) 2018-08-13 2019-03-11 ナノ乳化による製剤化カンナビス油粉末、その製造方法、及びその使用

Country Status (9)

Country Link
US (2) US11712430B2 (https=)
EP (1) EP3716946A1 (https=)
JP (1) JP2021535935A (https=)
CN (1) CN113473965A (https=)
AU (1) AU2019322212B2 (https=)
BR (1) BR112021009869A2 (https=)
CO (1) CO2021007647A2 (https=)
IL (2) IL261132A (https=)
WO (1) WO2020035850A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3138630A1 (en) * 2019-05-02 2020-11-05 Betterlife Pharma Inc. Cannabinoid stock transdermal formulations
US10780075B1 (en) 2019-07-31 2020-09-22 Etain IP, LLC Water soluble cannabis composition
CN114245739A (zh) * 2019-08-12 2022-03-25 腾思凯真私人有限公司 大麻二酚口腔崩解片
KR20230047095A (ko) 2020-07-29 2023-04-06 카낙 테크놀로지스, 엘엘씨 치료용 친유성 활성물질의 개선된 전달을 위한 약제학적 조성물
KR20220128405A (ko) * 2020-07-29 2022-09-20 카낙 테크놀로지스, 엘엘씨 화장용 사용을 위한 친지성 물질의 개선된 포뮬레이션
IL293086A (en) 2020-07-29 2022-07-01 Karnak Tech Llc Formulations of orally administered lipophilic dietary supplements and beneficial oils
CA3188864A1 (en) * 2020-08-14 2022-02-17 Ori LIEBERMAN Dosing capsule made from cannabis-derived resin and methods of making the same
CA3114085A1 (en) * 2021-04-05 2022-10-05 MEC11S Inc. Composition comprising cannabis extracts and method of manufacturing same
JP2023010676A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物
AU2024305502A1 (en) 2023-06-16 2026-01-08 Pico Ip, Llc A process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles
WO2026037496A1 (en) * 2024-08-14 2026-02-19 Tetra Pharm Technologies A self-emulsifying solid composition comprising a cannabinoid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013518097A (ja) * 2010-01-26 2013-05-20 イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー 肺高血圧を予防および治療するための組成物および方法
US8629177B2 (en) * 2010-08-24 2014-01-14 Aphios Corporation Nanoencapsulated delta-9-tetrahydrocannabinol
ES2739194T3 (es) 2012-01-19 2020-01-29 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Formulación y método para aumentar la biodisponibilidad oral de fármacos
JP6247685B2 (ja) 2012-05-16 2017-12-13 メワ・シン 実質的に水不溶性の薬物の送達のための医薬組成物
WO2015171445A1 (en) 2014-05-06 2015-11-12 Mewa Singh Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
US20160058866A1 (en) 2014-09-02 2016-03-03 Ronald D. Sekura Alternative solutions for the administration of cannabis derived botanical products
US9629886B2 (en) 2015-02-24 2017-04-25 Ers Holdings, Llc Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
WO2016147186A1 (en) 2015-03-19 2016-09-22 One World Cannabis Ltd Preparations of cannabis emulsions and methods thereof
CA2986268C (en) * 2015-05-28 2024-01-02 Insys Development Company, Inc. Stable cannabinoid formulations
BR102015024165A2 (pt) * 2015-09-18 2017-03-28 Prati Donaduzzi & Cia Ltda composição farmacêutica oral compreendendo canabinóide, processo para sua preparação e seu uso
AU2016347651A1 (en) * 2015-10-26 2018-05-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Novel cannabinoid formulations
JP2019511580A (ja) 2016-04-15 2019-04-25 エスアールイー ウェルネス インク.Sre Wellness Inc. 乳化剤を使用して大麻油を親水性にする方法及び関連するカンナビノイド組成物
JP2020514282A (ja) * 2016-12-20 2020-05-21 ティルレイ,インコーポレイティド 新規カンナビノイド組成物および使用方法
CO2017007962A1 (es) * 2017-08-04 2018-04-19 Alsec Alimentos Secos S A S Nanoparticulas oleosas de cannabis microencapsuladas en polvo

Similar Documents

Publication Publication Date Title
JP2021535935A5 (https=)
EP1476473B1 (en) Novel natural cyclodextrin complexes
US20230321031A1 (en) Formulated Cannabis Oil Powder By Nanoemulsifycation, Methods Of Producing And Uses Thereof
CA2476833C (en) Novel methylated cyclodextrin complexes
Guan et al. Anti-rheumatic effect of quercetin and recent developments in nano formulation
US20160058866A1 (en) Alternative solutions for the administration of cannabis derived botanical products
US20230087359A1 (en) Cannabinoid compositions and methods of use thereof
JPWO2020035850A5 (https=)
US20210137877A1 (en) Products and methods for using cannabidiol in combination with melatonin to induce sleep
JP2025182116A (ja) 高親油性生理活性物質の放出制御製剤
WO2020146478A1 (en) Cannabinoid formulations for treating alcohol hangover
US20180263954A1 (en) Sustained Release Cannabinoid Formulations
US11285184B2 (en) Cannabidiol alkaline composition
Al-Khazaleh et al. Elucidating the neuroinflammatory and neuroprotective activity of phytochemicals in Cannabis Sativa and their potential entourage effects
Verma et al. Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases
Kale et al. Phytosomes: An Emerging Nanocarrier System for Enhancing the Bioavailability of Quercetin
Marwaha et al. Role of Phytocompounds: Synergism Between Nanomaterial and Medicinal Plants
WO2024097327A1 (en) Cannabinoid formulations and use for treatment of emotional disorders and sexual dysfunction
JP2026034780A (ja) 高親油性生理活性物質の放出制御製剤
JPWO2020177819A5 (https=)
JPWO2020177818A5 (https=)